a From the Department of Internal Medicine, University of Cincinnati College of Medicine; Division of Hematology Oncology, UC Department of Pediatrics, Cincinnati Children’s Hospital; and the Divisions of Pathology and Hematology and Oncology, University of Cincinnati College of Medicine, Cincinnati, Ohio.
Hepatic epithelioid hemangioendothelioma (HEHE) is a rare hepatic vascular tumor that represents a diagnostic challenge. The rarity of this neoplasm precludes establishment of a standard-of-care treatment. Risk factors for HEHE are not well-known. Liver transplant remains the most common therapeutic modality for nonmetastatic disease. This article describes a patient who presented with abdominal pain, fatigue, poor appetite, and weight loss. Genetic testing showed that the patient was homozygous for C282Y consistent with hereditary hemochromatosis, and liver biopsy was consistent with malignant epithelioid hemangioendothelioma. The patient was referred for a liver transplant but was deemed inappropriate for transplant secondary to peritoneal studding, with frozen-section analysis showing metastatic disease at the time of surgery.
Correspondence: Nagla Abdel Karim, MD, PhD, Division of Hematology and Oncology, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267. E-mail: karimnf@UCMAIL.UC.EDU